ElleS review
ElleS (ElleS Inc.) is a comprehensive compounded telehealth service.
- Scores never bought
- 497 providers tracked
- Every factor auditable
- Updated July 2026
ElleS earns a Match Score of 50/100 (grade C) and sits #437 of 497 on our board under the balanced default weighting.
- Semaglutide
- Not disclosed
- Tirzepatide
- Not disclosed
- Coverage
- Coverage not published
- Brand-name
- Compounded only
- Oral option
- Yes
- Verification
- LegitScript-certified
Best for: Shoppers wanting compounded GLP-1 (including oral capsules) within a broad telehealth menu.
MatchScript's take: Our #437 pick of 497 — one of the few with a non-injection route, scored on the same six factors as everyone else.
The factor breakdown
ElleS on the six Match Score factors — the same sub-scores the quiz reweights to your priorities. See the methodology.
Its lowest tier isn't clearly disclosed puts Budget Fit at a below-par 48 — above the budget tiers.
Limited or undisclosed state coverage can slow your start, for a below-par 58 on Speed to Start.
ElleS adds an oral/sublingual route on top of injectables, for a below-par 51 on Formulary Match.
Support lands at a middling 78 — lighter, meds-first support.
Flexibility scores a below-par 20 — fewer levers to flex your plan.
LegitScript certification and clear public disclosures give a below-par 46 on Transparency.
Pricing in context
How ElleS's monthly price sits against the category median and the cheapest provider we track.
What we like
- Compounded semaglutide and tirzepatide in both injectable and oral-capsule forms, plus microdose options
- Packages bundle the telehealth visit, medication, and shipping; Registered Dietitian support included
- Full legal suite published — Terms, Privacy Policy, Privacy Practices, and Medical Consent
- Broad menu: also TRT, HRT (estradiol), sexual health, hair loss, and longevity (sermorelin, NAD+)
The caveats
- Pricing not shown publicly — products and costs appear only after the intake flow
- Sold as 3- and 6-month packages rather than simple monthly plans
- Compounding pharmacy partner not named ('made in licensed US facilities')
- Not LegitScript-certified (no certification displayed)
Who it's for — and who should skip it
Choose ElleS if shoppers wanting compounded GLP-1 (including oral capsules) within a broad telehealth menu.
Skip it if that doesn't sound like you. A closer fit may be Actin (Match Score 50) — or take the quiz to see where ElleS lands for your priorities.
How it compares to CoreAge Rx & the closest scorer
ElleS against our #1 overall pick and the provider that scores closest to it. Green marks the row leader.
| How it compares | ElleSthis provider | CoreAge Rxour #1 | Actinclosest scorer |
|---|---|---|---|
| Sema price | Not disclosed | $149/mo | $169/mo (compounded) |
| Coverage | Coverage not published | All 50 states | Coverage not published |
| Formulary | Injectable + oral | Injectable | Injectable |
| Match Score | 50 · C | 91 · A− | 50 · C |
ElleS, answered
Is ElleS legit?
Yes — ElleS is LegitScript-certified, a third-party check that a telehealth pharmacy operates within the rules. Like most programs here it dispenses compounded GLP-1s, which are made by a licensed pharmacy but aren't FDA-approved; confirm your prescriber is US-licensed at intake.
How much does ElleS cost?
ElleS doesn't publish a clear compounded-semaglutide price up front. You'll typically see full pricing after the intake questionnaire. Get the all-in monthly number in writing before you pay.
Does ElleS ship to my state?
ElleS operates in a limited set of states (Coverage not published). If yours isn't on that list, you'll need a nationwide provider instead.
ElleS vs CoreAge Rx — which is better?
Both are on our board. ElleS scores 50/100; CoreAge Rx leads our default ranking at 91/100 for its flat nationwide pricing on both molecules and easy cancellation. ElleS can still win for you if its strengths match your priorities — best for: Shoppers wanting compounded GLP-1 (including oral capsules) within a broad telehealth menu. Run the quiz to see which comes out ahead for you.
Pricing & state data last verified June 2026 from ElleS's public site and our master provider matrix. The Match Score and its sub-scores are our editorial judgment per the methodology. Commercial facts only — prices change, so confirm on ElleS's site. Not medical advice; see our disclosure.
ElleS earns a Match Score of 50/100 (grade C) and sits #437 of 497 on our board under the balanced default weighting. ElleS (ElleS Inc.) is a comprehensive compounded telehealth service. Best for: Shoppers wanting compounded GLP-1 (including oral capsules) within a broad telehealth menu. If it isn't the right fit, Actin is a sensible alternative to weigh next.
Compare with other providers
Our next-best picks in default ranking order, then the 24 programs that sit nearest ElleS on the board.
- #1Match91/ 100CoreAge RxThe best all-around match: nationwide access, both molecules at one flat, no-surprise price, and an easy exit.91/100
- #2Match88/ 100Strut HealthThe only program here carrying both LegitScript and ACHC accreditation, with an oral lozenge route on both molecules at the cheapest entry on this board.88/100
- #3Match86/ 100HealthRXA LegitScript-certified, physician-supervised program with a rare oral GLP-1 tablet alongside injectables — both molecules, transparent no-insurance pricing, and a brand-name path.86/100
- #4Match86/ 100ShedRxA weight-focused program that also offers an oral/sublingual route for the needle-averse.86/100
- #5Match88/ 100Ondra HealthNear rock-bottom pricing on both molecules plus some brand access — a rare budget-and-breadth combo, nationwide.88/100
Compare 24 nearby providersHide them
| Provider | Tirzepatide price | Coverage | Alternatives | Go | ||
|---|---|---|---|---|---|---|
| eMed#438 | 50 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| FlyteHealth#439 | 50 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Fridays#440 | 50 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| G-Plans#441 | 50 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Ilant Health#442 | 50 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Iron Med RX#443 | 50 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Medical Health Institute#444 | 50 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Midi Health#445 | 50 | Not disclosed | Not disclosed | All 50 states | Alternatives | Visit |
| PrescribedRX#446 | 50 | $189/mo (compounded) | $276/mo (compounded) | Coverage not published | Alternatives | Visit |
| RxION Health#447 | 50 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Vida Health#448 | 50 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Zealthy#449 | 50 | $286/mo (starting dose, plus a separate fee, compounded) | $351/mo (starting dose, plus a separate fee, compounded) | 34 states | Alternatives | Visit |
| Aspire Health#450 | 49 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Elevate Health#451 | 49 | $299/mo (compounded) | $399/mo (compounded) | Coverage not published | Alternatives | Visit |
| Enara Health#452 | 49 | Not disclosed | Not disclosed | 6 states | Alternatives | Visit |
| Evolve Telemed#453 | 49 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Garcia Weight Loss, Aesthetics & Hormone Therapy#454 | 49 | $400/mo (starting dose, compounded) | Not disclosed | 1 states | Alternatives | Visit |
| Genesis Lifestyle Medicine#455 | 49 | Not disclosed | Not disclosed | 8 states | Alternatives | Visit |
| MDExam#456 | 49 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| MultiMedRx#457 | 49 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Omzo#458 | 49 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| RegenCen#459 | 49 | Not disclosed | Not disclosed | 2 states | Alternatives | Visit |
| Royal Medical Center#460 | 49 | Not disclosed | $450/mo (2.5 mg dose, compounded) | Coverage not published | Alternatives | Visit |
| Tablet Health#461 | 49 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |